Hepatology
Latest News
Can We Repurpose Obesity Drugs to Reverse Liver Disease?
A new retrospective observational study offers evidence that GLP-1 RAs may have a direct impact on MASLD,...
Latest News
New Guidelines Emphasize Liver Care in T2D, Obesity
The guideline recognizes that individuals with type 2 diabetes or obesity with additional metabolic risk factor(s) are at a higher risk for MASLD...
Feature
AI-Assisted Pathology Poised to Transform Liver Disease Care
The standardization and reproducibility offered by AI-driven technology could facilitate more consistent diagnoses across different healthcare...
News from the FDA/CDC
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
The drug combo was the first programmed death–ligand 1 inhibitor to gain approval for subcutaneous administration.
News
Baveno VI Criteria Appear Cost-Effective for Detecting Varices in Cirrhosis
Previous research indicates that the expanded criteria could avoid double the number of endoscopies.
Latest News
Not Kidding: Yellow Dye 5 May Lead to Invisibility
Study found that yellow dye led to temporarily transparent skin in mice, making vessels, muscle, and organs visible.
From the Journals
Statins Linked to Improved Liver Health in MASLD
Statin usage was associated with a 76.7% lower risk for all-cause mortality and a 62% lower risk of liver-related events than non-use.
Latest News
Alcohol-Associated Liver Disease’s Changing Demographics
Recent data have identified three demographic groups experiencing higher rates of ALD relative to previous periods and who may therefore require...
Latest News
Could Adipose Tissue Be a Better Measure for Obesity Than BMI?
BMI cutoffs are based primarily on mortality data collected from large non-Hispanic White populations, without data on potential differences by...
News from the FDA/CDC
FDA Grants Livdelzi Accelerated Approval for Primary Biliary Cholangitis
The FDA approved Livdelzi based largely on results of the phase 3 RESPONSE study.
From the Journals
Are Your Patients Using Any of These Six Potentially Hepatotoxic Botanicals?
An estimated 15.6 million adults in the United States consumed at least one potentially hepatotoxic botanical product in the past 30 days, with...